Bacterial Infections
Welcome,         Profile    Billing    Logout  
 127 Companies   123 Products   123 Products   59 Mechanisms of Action   6 Trials   3245 News 


«12...1516171819202122232425...6566»
  • ||||||||||  Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD)
    Trial completion, Pneumococcal vaccines:  A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) (clinicaltrials.gov) -  Feb 27, 2016   
    P3,  N=130, Completed, 
    Not yet recruiting --> Recruiting Terminated --> Completed
  • ||||||||||  Enbrel (etanercept) / Pfizer, Amgen
    Trial completion:  Etanercept for Treatment of Hidradenitis (clinicaltrials.gov) -  Feb 27, 2016   
    P2,  N=15, Completed, 
    No longer recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Trial primary completion date:  INFECIR2: The INFECIR-2 Albumin Prevention Study (clinicaltrials.gov) -  Feb 18, 2016   
    P4,  N=512, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Dec 2017
  • ||||||||||  rifampicin/isoniazid/ethambutol/pyrazinamide / Generic mfg.
    Enrollment closed:  Essentiality of INH in TB Therapy (clinicaltrials.gov) -  Feb 18, 2016   
    P2,  N=69, Active, not recruiting, 
    N=458 --> 310 Recruiting --> Active, not recruiting
  • ||||||||||  Altabax (retapamulin) / GSK, Almirall
    Trial completion, Enrollment change, Trial primary completion date:  Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection (clinicaltrials.gov) -  Feb 18, 2016   
    P4,  N=38, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=75 --> 38 | Trial primary completion date: Apr 2012 --> Nov 2012
  • ||||||||||  Biomarker, Trial completion, Enrollment change, IO biomarker:  BIONEC: Biomarkers in Patients With Flesh-eating Bacterial Infections (clinicaltrials.gov) -  Feb 17, 2016   
    P=N/A,  N=169, Completed, 
    Active, not recruiting --> Recruiting | N=12 --> 36 | Trial primary completion date: Mar 2016 --> Nov 2017 Recruiting --> Completed | N=114 --> 169
  • ||||||||||  ExPEC-4V / J&J, GSK
    Trial completion:  Vaccine Against Escherichia Coli Infection (clinicaltrials.gov) -  Feb 11, 2016   
    P1,  N=194, Completed, 
    Initiation date: Jan 2016 --> May 2016 | Trial primary completion date: Jun 2016 --> Jan 2017 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  ICTBSG: Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis (clinicaltrials.gov) -  Feb 11, 2016   
    P3,  N=403, Completed, 
    Trial primary completion date: Feb 2016 --> Jan 2017 Active, not recruiting --> Completed | Trial primary completion date: Jun 2011 --> Jun 2012
  • ||||||||||  Trial completion, Trial primary completion date, IO biomarker:  Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology (clinicaltrials.gov) -  Feb 10, 2016   
    P1,  N=50, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Jun 2011 --> Jun 2012 Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Nov 2015
  • ||||||||||  Trial completion, Enrollment change:  Detection of Mycoplasma Pneumoniae (clinicaltrials.gov) -  Feb 8, 2016   
    P=N/A,  N=471, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015 Recruiting --> Completed | N=800 --> 471
  • ||||||||||  sodium phenylbutyrate / Generic mfg.
    Trial completion, Trial primary completion date:  IRETB: Immune Reconstitution in Tuberculosis Disease (clinicaltrials.gov) -  Feb 5, 2016   
    P2,  N=390, Completed, 
    Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Gown and Glove Use to Prevent the Spread of Infection in VA Community Living Centers (clinicaltrials.gov) -  Feb 4, 2016   
    P=N/A,  N=203, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Enrolling by invitation --> Active, not recruiting | N=400 --> 203 | Trial primary completion date: Aug 2015 --> Jan 2016
  • ||||||||||  Trial completion, Enrollment change:  Gene Expression in HIV and Tuberculosis Co-infection (clinicaltrials.gov) -  Feb 3, 2016   
    P=N/A,  N=20, Completed, 
    Active, not recruiting --> Completed | N=400 --> 232 Recruiting --> Completed | N=265 --> 20